Udit Batra

Udit Batra is a President and Chief Executive Officer of Waters, Inc.(WAT)

Udit Batra brings more than two decades of leadership and operational expertise in healthcare and life sciences. He has a proven track record of leading multi-billion-dollar global organizations and driving results at the top of the industry.

Before joining Waters in September 2020, Udit served as CEO of MilliporeSigma, a global business with $8 Billion in sales and over 22,000 employees. In 2015, Udit led the formation of MilliporeSigma, the largest merger in the life science tools industry at the time and built it into one of the top performers in the industry with record sales growth and margin development. From 2011-2013, as CEO of Merck KGaA’s consumer health business, Udit led a period that doubled the business’s profitability and achieved organic growth in the top tier of the industry.

Earlier in his career, Udit served in a range of leadership positions at Novartis. In addition to leading Corporate Strategy and Global Public Health and Market Access for Vaccines and Diagnostics, he also served as president of the Australia Pharma business. During his tenure, this subsidiary became the fastest-growing business amongst competitors in Australia and in Novartis. Throughout his career, Udit has championed science education, especially for low-income students, developed and promoted women’s leadership, and has been a strong advocate for increasing diversity across the organizations he has led.

Udit has received numerous leadership accolades and recognition, including 2022 PharmaVOICE Hall of Fame, 2021 Mass Technology Leadership Council’s Tech Top 50, 2020 New Englander of the Year by the New England Council, 2019 New England Choice Awards Business Person of the Year, PharmaVOICE Top 100 Most Inspirational People (2017 - 2019), Boston Business Journal’s 2019 Power 50, and the 2016 CPhl Pharma CEO of the Year.

Currently, Udit is a board member of Boston Children’s Hospital’s Trust Board and the Analytical, Life Science & Diagnostics Association (ALDA). He also serves on the Advisory Councils of the Chemical Engineering Departments of Princeton University where he earned his Ph.D. in Chemical Engineering and the University of Delaware where he earned a B.S. in Chemical Engineering.